医学
动脉粥样硬化
血管内超声
安慰剂
内科学
心脏病学
置信区间
冠状动脉粥样硬化
载脂蛋白B
胆固醇
冠状动脉疾病
病理
替代医学
作者
Steven E. Nissen,Taro Tsunoda,E. Murat Tuzcu,Paul Schoenhagen,Christopher B. Cooper,Muhammad Yasin,Gregory M. Eaton,Michael A. Lauer,W. Scott Sheldon,Cindy L. Grines,Stephen W. Halpern,Tim Crowe,James C. Blankenship,Richard A. Kerensky
出处
期刊：JAMA
[American Medical Association]
日期：2003-11-04
卷期号：290 (17): 2292-2292
被引量：1693
标识
DOI：10.1001/jama.290.17.2292
摘要
A recombinant ApoA-I Milano/phospholipid complex (ETC-216) administered intravenously for 5 doses at weekly intervals produced significant regression of coronary atherosclerosis as measured by IVUS. Although promising, these results require confirmation in larger clinical trials with morbidity and mortality end points.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
OsamaKareem
GingerF
lalala
arniu2008
无极微光
仰望喀纳斯的星空
Criminology34
chandangfo
乐空思
YifanWang
嘉心糖
XQQDD
369ninja
Hayat
dashen
互助
大布丁
千束
快点毕业
贪玩的秋柔
皖公网安备34019202002308
